6-methoxyindole-3-acetamide | 104295-51-4

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吲哚及其衍生物
• 英文名称: 6-methoxyindole-3-acetamide
• 英文别名: 6-methoxy-1H-indole-3-acetamide；6-Methoxy-indol-essigsaeure-(3)-amid；2-(6-methoxy-indol-3-yl)-acetamide；2-(6-Methoxy-1H-indol-3-yl)acetamide
• CAS: 104295-51-4
• 化学式: C₁₁H₁₂N₂O₂
• 分子量: 204.228
• InChiKey: ZHCAMBSURQLGBM-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  0.7
• 重原子数：
  15
• 可旋转键数：
  3
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.18
• 拓扑面积：
  68.1
• 氢给体数：
  2
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  6-methoxyindole-3-acetamide 在 palladium on activated charcoal potassium tert-butylate 、 氢气 、 magnesium 作用下， 以 四氢呋喃 、 甲醇 、 乙醇 为溶剂， 反应 50.0h， 生成 trans-3,4-bis-(6-methoxy-1H-indol-3-yl)-2,5-pyrrolidinedione
  参考文献：
  名称：

  Synthesis, determination of stereochemistry, and evaluation of new bisindole alkaloids from the myxomycete Arcyria ferruginea: An approach for Wnt signal inhibitor

  摘要：

  To determine the stereochemistry of dihydroarcyriarubin C (1), new bisindole alkaloid isolated from the myxomycete Arcyriajerruginea, cis- (2) and trans-dihydroarcyriarubin C (3) were synthesized. Comparison of their NMR characteristics allowed the trans stereochemistry of the natural product to be confirmed. Moreover, the Writ signal inhibitory activities of 2 and 3 were compared with that of arcyriaflavin C (4), which is a natural product containing a bond between C-2 and C-T. The cis-dihydroar-cyriarubin C (2) showed moderate inhibition of Wnt signal transcription, which suggests that bisindole frameworks might be useful as small-molecule Writ signal inhibitors. (c) 2007 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmcl.2007.05.033
• 作为产物：
  描述：

  (6-methoxy-1H-indol-3-yl)(oxo)acetyl chloride 在 ammonium hydroxide 、 sodium tetrahydroborate 、 三甲基氯硅烷 、 sodium iodide 作用下， 以 甲醇 、 乙腈 为溶剂， 反应 7.0h， 生成 6-methoxyindole-3-acetamide
  参考文献：
  名称：

  Synthesis, determination of stereochemistry, and evaluation of new bisindole alkaloids from the myxomycete Arcyria ferruginea: An approach for Wnt signal inhibitor

  摘要：

  To determine the stereochemistry of dihydroarcyriarubin C (1), new bisindole alkaloid isolated from the myxomycete Arcyriajerruginea, cis- (2) and trans-dihydroarcyriarubin C (3) were synthesized. Comparison of their NMR characteristics allowed the trans stereochemistry of the natural product to be confirmed. Moreover, the Writ signal inhibitory activities of 2 and 3 were compared with that of arcyriaflavin C (4), which is a natural product containing a bond between C-2 and C-T. The cis-dihydroar-cyriarubin C (2) showed moderate inhibition of Wnt signal transcription, which suggests that bisindole frameworks might be useful as small-molecule Writ signal inhibitors. (c) 2007 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmcl.2007.05.033

文献信息

• Synthetic Approaches to Indolo[6,7-<i>a</i>]pyrrolo[3,4-<i>c</i>]carbazoles:  Potent Cyclin D1/CDK4 Inhibitors
  作者：Margaret M. Faul、Thomas A. Engler、Kevin A. Sullivan、John L. Grutsch、Marcella T. Clayton、Michael J. Martinelli、Joseph M. Pawlak、Michael LeTourneau、D. Scott Coffey、Steven W. Pedersen、Stanley P. Kolis、Kelly Furness、Sushant Malhotra、Rima S. Al-awar、James E. Ray

  DOI：10.1021/jo035606v

  日期：2004.4.1

  Synthesis of indolo[6,7-a]pyrrolo[3,4-c]carbazoles 1, a new class of cyclin D1/CDK4 inhibitors, by oxidation of the corresponding aryl indolylmaleimides 2, will be described. Two approaches to the synthesis of 2 were identified that required new methods for the synthesis of 7-substituted indole acetamides 3 and N-methyl (indol-7-yl)oxoacetates 6. The chemistry developed enabled introduction of functionality

  将描述通过相应芳基吲哚基马来酰亚胺2的氧化合成吲哚并[6，7- a ]吡咯并[3，4- c ]咔唑1，一种新型的细胞周期蛋白D1 / CDK4抑制剂。确定了两种合成2的方法，它们需要新的合成7-取代的吲哚乙酰胺3和N-甲基（吲哚-7-基）氧乙酸酯6的新方法。开发出的化学试剂能够在C 12和N 13处引入官能团（-OR，NR 2），从而促进了吲哚并咔唑平台的结构活性关系（SAR）评估。
• Methods and compounds for treating proliferative diseases
  申请人：——

  公开号：US20040048915A1

  公开（公告）日：2004-03-11

  The compounds disclosed herein are indolocarbazoles of Formula (I), which are potent CDK4 inhibitors, and are useful in the treatment of cell proliferative disorders, including cancer. Formula (I). 1

  本公开的化合物是式(I)的吲哚咔巴醌，它们是有效的CDK4抑制剂，并且在治疗细胞增殖性疾病，包括癌症方面具有用处。Formula (I).
• Heterocyclic inhibitors of ERK2 and uses thereof
  申请人：——

  公开号：US20030092714A1

  公开（公告）日：2003-05-15

  Described herein are compounds that are useful as protein kinase inhibitors having the formula: 1 wherein Z 1 and Z 2 are each independently nitrogen or CH and Ring A, T m R 1 , QR 2 , U n R 3 , and Sp are as described in the specification. The compounds are especially useful as inhibitors of ERK2 and for treating diseases in mammals that are alleviated by a protein kinase inhibitor, particularly diseases such as cancer, inflammatory disorders, restenosis, diabetes, and cardiovascular disease.

  本文描述了一些化合物，这些化合物可用作蛋白激酶抑制剂，其化学式如下： 1 其中Z 1 和Z 2 分别独立地为氮或CH，环A，T m R 1 ，QR 2 ，U n R 3 和Sp如规范中所述。这些化合物特别适用于ERK2的抑制剂，并用于治疗通过蛋白激酶抑制剂缓解的哺乳动物疾病，特别是癌症、炎症性疾病、再狭窄、糖尿病和心血管疾病等疾病。
• Agents and methods for the treatment of proliferative diseases
  申请人：——

  公开号：US20030229026A1

  公开（公告）日：2003-12-11

  The present invention provides selective kinase inhibitors of formula (I). 1

  这项发明提供了式（I）的选择性激酶抑制剂。
• Novel, potent and selective cyclin D1/CDK4 inhibitors: indolo[6,7-a]pyrrolo[3,4-c]carbazoles
  作者：Thomas A. Engler、Kelly Furness、Sushant Malhotra、Concha Sanchez-Martinez、Chuan Shih、Walter Xie、Guoxin Zhu、Xun Zhou、Scott Conner、Margaret M. Faul、Kevin A. Sullivan、Stanley P. Kolis、Harold B. Brooks、Bharvin Patel、Richard M. Schultz、Tammy B. DeHahn、Kashif Kirmani、Charles D. Spencer、Scott A. Watkins、Eileen L. Considine、Jack A. Dempsey、Catherine A. Ogg、Nancy B. Stamm、Bryan D. Anderson、Robert M. Campbell、Vasu Vasudevan、Michelle L. Lytle

  DOI：10.1016/s0960-894x(03)00461-x

  日期：2003.7

  The synthesis and CDK inhibitory properties of a series of indolo[6,7-a]pyrrolo[3,4-c]carbazoles is reported. In addition to their potent CDK activity, the compounds display antiproliferative activity against two human cancer cell lines. These inhibitors also effect strong G1 arrest in these cell lines and inhibit Rb phosphorylation at Ser780 consistent with inhibition of cyclin D1/CDK4.

  报道了一系列吲哚[6，7-a]吡咯并[3，4-c]咔唑的合成和CDK抑制性能。这些化合物除了具有强大的CDK活性外，还具有针对两种人类癌细胞系的抗增殖活性。这些抑制剂还影响这些细胞系中的强G1阻滞，并抑制Ser780处的Rb磷酸化，这与抑制细胞周期蛋白D1 / CDK4一致。